Added to YB: 2025-04-09
Pitch date: 2025-04-07
TMDX [neutral]
TransMedics Group, Inc.
+69%
current return
Author Info
MMMT Wealth is a CPA who shares stock pitches in their newsletter. Sign up for the newsletter.
Company Info
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally.
Market Cap
$4.5B
Pitch Price
$72.87
Price Target
N/A
Dividend
N/A
EV/EBITDA
35.52
P/E
51.63
EV/Sales
7.99
Sector
Health Care Equipment and Supplies
Category
growth
Tariffs? These Stocks Won't Care - TransMedics Group, Inc.
TMDX (tariff overview): Recession-proof medtech growing 50% at 4.6x fwd sales. US-based production, controlled supply chain. Q1 flights +20% vs Q4, signaling strong earnings. Outperforming peers (ISRG, PRCT, LMAT) in recent market. Potential for big Q1 beat & guidance raise. $67 share price an 'incredible deal'.
Read full article (2 min)